Omar Abudayyeh Launches Helios, a Home Blood Test of 1,000 Plus Proteins With an AI Agent
Introducing Helios: measuring 1,000+ protein biomarkers from a drop of blood to help you live younger, longer. Here’s how it works: • Self-collect blood at home with a painless, needle-free device • We measure the proteins carrying signals from cells and organs throughout your body • Your Helios AI agent explains your results, highlights risks, and offers personalized guidance Proudly backed by Y Combinator and Formation VC. Join the waitlist at
Context
A consumer test that claims to read more than a thousand protein signals from a home blood sample, then explain them with an agent, is a serious health product pitch, but it is still a launch claim, not a clinical result.
Omar Abudayyeh posted that Helios measures 1,000 plus protein biomarkers from a drop of blood, with a home, needle free collection device, a lab measurement of proteins that carry signals from cells and organs, and a Helios AI agent that explains results, highlights risks, and offers personalized guidance. He said the company is backed by Y Combinator and Formation VC, and pointed to a waitlist at myhelios.com. The health benefit language in the post is the company's own pitch.
Deep dive
Omar Abudayyeh, posting as the founder, introduced Helios as a way to measure more than 1,000 protein biomarkers from a drop of blood, 'to help you live younger, longer.' He described a three step path: self collect blood at home with a painless, needle free device; measure the proteins that carry signals from cells and organs throughout the body; and have a Helios AI agent explain the results, highlight risks, and offer personalized guidance. He said the company is proudly backed by Y Combinator and Formation VC, and pointed to a waitlist.
Those steps and the 1,000 plus biomarker figure are first hand product claims from the founder. The 'live younger, longer' line, the painless device, and the agent's risk guidance are marketing and should not be read as a clinical trial result or as medical advice. The post does not name a lab partner, a clearance, a price, or a published validation of the protein panel.
A home proteomics test plus an agent that interprets it would be a notable consumer health product if the measurements are real and the explanations are careful. This file cannot confirm either from the launch post alone.
Because the lead is the founder, the product name, the Y Combinator and Formation backing, and the waitlist are confirmed as his announcement. The health outcomes are not.
What to expect next
The Helios site should add price, availability, the device's method, and any validation or clearance. Watch for a paper or a methods page on the 1,000 plus protein panel, and for how the agent phrases risk, which will matter for safety. If a medical regulator or a lab partner posts, that should be added. This story should not be treated as a proven longevity product until those results exist.
